<DOC>
	<DOCNO>NCT01753115</DOCNO>
	<brief_summary>The purpose clinical trial determine whether effect antibiotic , ciprofloxacin take administration 3-dose series BioThraxÂ® ( Anthrax Vaccine Adsorbed AVA ) . This study conduct United States ( US ) 154 healthy male female volunteer subject age 18 45 . The duration study participation subject approximately 76 day ( approximately 2.5 month )</brief_summary>
	<brief_title>Ciprofloxacin BioThrax Co-Administration Study</brief_title>
	<detailed_description>BioThrax FDA-licensed vaccine prevention anthrax infection . This randomized , open-label , Phase 2 , multi-center trial investigate potential interaction ciprofloxacin BioThrax .</detailed_description>
	<mesh_term>Anthrax</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<criteria>Be 18 45 year age , time enrollment Be good health determine investigator medical history physical examination . If premenopausal female , must use acceptable method birth control . Be willing able return followup visit blood urine collection duration trial Be willing able complete webenabled electronic diary report concomitant medication , adverse event , BioThrax reactogenicity event trial Be able understand communicate English . Prior immunization anthrax vaccine know exposure anthrax organism Intend enlist military study . Have know allergy aluminum hydroxide , formaldehyde , benzethonium chloride , latex . Plan receive experimental product 30 day prior study entry time study Have receive live vaccine 30 day study entry Plan receive live vaccine time study . Have ongoing drug abuse/dependence ( include alcohol ) issue and/or test positive urine drug screen amphetamine , barbiturate , cocaine opiate Have receive immunosuppressive therapy ( include systemic steroid ) within 30 day prior trial entry Have condition know produce associate immunosuppression Have receive cytotoxic therapy previous 5 year A chronic condition , opinion Investigator , would render vaccination unsafe would interfere trial evaluation completion study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>post-exposure prophylaxis</keyword>
	<keyword>toxin neutralization assay</keyword>
</DOC>